Literature DB >> 18516040

A Toll-like receptor 2-integrin beta3 complex senses bacterial lipopeptides via vitronectin.

Gisa Gerold1, Khalid Abu Ajaj, Michael Bienert, Hans-Jürgen Laws, Arturo Zychlinsky, Juana L de Diego.   

Abstract

Toll-like receptor 2 (TLR2) initiates inflammation in response to bacterial lipopeptide (BLP). However, the molecular mechanisms enabling the detection of BLP by TLR2 are unknown. Here we investigated the interaction of BLP with human serum proteins and identified vitronectin as a BLP-recognition molecule. Vitronectin and its receptor, integrin beta(3), were required for BLP-induced TLR2-mediated activation of human monocytes. Furthermore, monocytes from patients with Glanzmann thrombasthenia, which lack integrin beta(3), were completely unresponsive to BLP. In addition, integrin beta(3) formed a complex with TLR2 and this complex dissociated after BLP stimulation. Notably, vitronectin and integrin beta(3) coordinated responses to other TLR2 agonists such as lipoteichoic acid and zymosan. Our findings show that vitronectin and integrin beta(3) contribute to the initiation of TLR2 responses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18516040     DOI: 10.1038/ni.1618

Source DB:  PubMed          Journal:  Nat Immunol        ISSN: 1529-2908            Impact factor:   25.606


  38 in total

Review 1.  Accessory molecules for Toll-like receptors and their function.

Authors:  Clarissa C Lee; Ana M Avalos; Hidde L Ploegh
Journal:  Nat Rev Immunol       Date:  2012-02-03       Impact factor: 53.106

2.  αvβ3 Integrin Boosts the Innate Immune Response Elicited in Epithelial Cells through Plasma Membrane and Endosomal Toll-Like Receptors.

Authors:  Costanza Casiraghi; Tatiana Gianni; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2016-03-28       Impact factor: 5.103

3.  Sepsis lethality via exacerbated tissue infiltration and TLR-induced cytokine production by neutrophils is integrin α3β1-dependent.

Authors:  Yelena V Lerman; Kihong Lim; Young-Min Hyun; Kathleen L Falkner; Hongmei Yang; Anthony P Pietropaoli; Arnoud Sonnenberg; Pranita P Sarangi; Minsoo Kim
Journal:  Blood       Date:  2014-10-02       Impact factor: 22.113

4.  Proteomics identification of ITGB3 as a key regulator in reactive oxygen species-induced migration and invasion of colorectal cancer cells.

Authors:  Yunlong Lei; Kai Huang; Cong Gao; Quek Choon Lau; Hua Pan; Ke Xie; Jingyi Li; Rui Liu; Tao Zhang; Na Xie; Huey Shan Nai; Hong Wu; Qiang Dong; Xia Zhao; Edouard C Nice; Canhua Huang; Yuquan Wei
Journal:  Mol Cell Proteomics       Date:  2011-05-27       Impact factor: 5.911

5.  Evasion of Toll-like receptor 2 activation by staphylococcal superantigen-like protein 3.

Authors:  B W Bardoel; R Vos; T Bouman; P C Aerts; J Bestebroer; E G Huizinga; T H C Brondijk; J A G van Strijp; C J C de Haas
Journal:  J Mol Med (Berl)       Date:  2012-06-20       Impact factor: 4.599

Review 6.  Integration of Canonical and Noncanonical Pathways in TLR4 Signaling: Complex Regulation of the Wound Repair Program.

Authors:  Paula J McKeown-Longo; Paul J Higgins
Journal:  Adv Wound Care (New Rochelle)       Date:  2017-10-01       Impact factor: 4.730

Review 7.  Cross-regulation of signaling by ITAM-associated receptors.

Authors:  Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2009-03-19       Impact factor: 25.606

8.  αvβ3-integrin is a major sensor and activator of innate immunity to herpes simplex virus-1.

Authors:  Tatiana Gianni; Valerio Leoni; Liudmila S Chesnokova; Lindsey M Hutt-Fletcher; Gabriella Campadelli-Fiume
Journal:  Proc Natl Acad Sci U S A       Date:  2012-11-12       Impact factor: 11.205

9.  Type I interferon and NF-κB activation elicited by herpes simplex virus gH/gL via αvβ3 integrin in epithelial and neuronal cell lines.

Authors:  Tatiana Gianni; Valerio Leoni; Gabriella Campadelli-Fiume
Journal:  J Virol       Date:  2013-10-09       Impact factor: 5.103

10.  CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer.

Authors:  Cameron R Stewart; Lynda M Stuart; Kim Wilkinson; Janine M van Gils; Jiusheng Deng; Annett Halle; Katey J Rayner; Laurent Boyer; Ruiqin Zhong; William A Frazier; Adam Lacy-Hulbert; Joseph El Khoury; Douglas T Golenbock; Kathryn J Moore
Journal:  Nat Immunol       Date:  2009-12-27       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.